Publications

January 2024
Article

A Cost Model for a Low Threshold Clinic Treating Opioid Use Disorder

By: Sarah E. Wakeman, Elizabeth Powell, Syed Shehab, Grace Herman, Laura Kehoe and Robert S. Kaplan

The US fee-for-service payment system under-reimburses clinics offering access to comprehensive treatments for opioid use disorder (OUD). The funding shortfall limits a clinic’s ability to expand and improve access, especially for socially marginalized patients with... View Details

Keywords: Health Care and Treatment; Cost; Equality and Inequality; Health Industry

July 2011
Article

Kidney Paired Donation

By: C. Bradley Wallis, Kannan P. Samy, Alvin E. Roth and Michael A. Rees

Kidney paired donation (KPD) was first suggested in 1986, but it was not until 2000 when the first paired donation transplant was performed in the U.S. In the past decade, KPD has become the fastest growing source of transplantable kidneys, overcoming the barrier faced... View Details

Keywords: Philanthropy and Charitable Giving; Health Care and Treatment; Growth and Development Strategy; Success; Problems and Challenges; Programs; System; United States

Read Now

12 Jul 2016
First Look

July 12, 2016

gaining information. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=51329 July–August 2016 Harvard Business Review How to Pay for Health Care By: Porter, Michael E., and Robert S. Kaplan Abstract—The United States stands... View Details

Keywords: Sean Silverthorne

September 2009
Case

The Risk Management Foundation of the Harvard Medical Institutions, Inc.

By: Richard M.J. Bohmer, Stephen P. Bradley and Natalie Kindred

Through its uniquely proactive approach to medical malpractice risk management, the Risk Management Foundation (RMF) has decreased claims—and premiums—for the Harvard hospitals it insures. The RMF is the captive medico-legal insurer of the Harvard medical institutions... View Details

Keywords: Cost Management; Insurance; Health Care and Treatment; Risk Management; Performance Improvement; Safety; Health Industry; Health Industry; Boston

01 Oct 2001
Research & Ideas

How To Make Restructuring Work for Your Company

hospital business and a health insurance business, management decided to split the businesses apart through a corporate spin-off because it realized the businesses were strategically incompatible—the customers of one business were... View Details

Keywords: by Stuart C. Gilson

July 2001 (Revised August 2005)
Case

Medicines Company, The

By: John T. Gourville

It is early 2001 and the Medicines Co. just received FDA approval to market Angiomax, a blood thinner to be used during angioplasties and heart procedures. It is intended to be a better alternative to Heparin, an 80-year-old drug that costs less then $10 per dose. The... View Details

Keywords: Business Model; Change Management; Decision Choices and Conditions; Cost Management; Price; Product Marketing; Product Launch; Product Development; Risk and Uncertainty; Health Industry; Health Industry

January 2017 (Revised October 2023)
Case

Classtivity: Payal's Pirouette

By: Jeffrey J. Bussgang and Olivia Hull

A few months after launching a new fitness technology product, the small staff of New York startup Classtivity gathers on a Saturday in April 2013 to take stock. With one successful pivot under its belt, Classtivity is finally generating revenue and enthusiasm among... View Details

August 2022 (Revised August 2023)
Case

Sweet Teez Bakery: Projecting the Dough’s Rise

By: Emily R. McComb, Mel Martin and Amy Klopfenstein

In 2021, the HBS Impact Investment Fund student team met with entrepreneur Teresa Maynard, who had applied for a $25,000 impact investment loan. The students thought the former Harvard Data Scientist’s bakery business, Sweet Teez Bakery, showed promise. Maynard had... View Details

Keywords: Impact Investment; Entrepreneurship; Social Entrepreneurship; Finance; Investment; Goods and Commodities; Financial Reporting; Small Business; Food and Beverage Industry; United States; Massachusetts

January 2024
Article

Cost of Exempting Sole Orphan Drugs from Medicare Negotiation

By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome

Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details

Keywords: Health Care and Treatment; Insurance; Price; Health Industry

15 Jun 2010
First Look

First Look: June 15

at the firm level, we can directly address how the composition of firms raising finance varies through time. We find strong evidence of substitution from bank loans to bonds at times characterized by tight lending standards, high levels... View Details

Keywords: Martha Lagace

January 2023
Case

Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery

By: Regina Herzlinger and Brian Walker

What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details

Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry

12 Aug 2014
First Look

First Look: August 12

http://hbr.org/product/salauno-eliminating-needless-blindness-in-mexico/an/814041-PDF-ENG Harvard Business School Case 114-077 Building a High Performance Culture at IDFC IDFC was set up in 1997 to direct private finance to infrastructure... View Details

Keywords: Sean Silverthorne

September 2009 (Revised May 2011)
Case

Acumen Fund: Measurement in Impact Investing (A)

By: Alnoor Ebrahim and V. Kasturi Rangan

Acumen Fund is a global venture capital firm with a dual purpose: it looks for a return on its investments, and it also seeks entrepreneurial solutions to global poverty. This case examines Acumen's new projects in Kenya. The organization's investment committee and its... View Details

Keywords: Decision Choices and Conditions; Venture Capital; Investment Return; Philanthropy and Charitable Giving; Risk Management; Corporate Social Responsibility and Impact; Business and Government Relations; Social Enterprise; Financial Services Industry; Kenya

December 2022
Article

The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies

By: Pragya Kakani, Michael Chernew and Amitabh Chandra

Context: To what extent does pharmaceutical revenue growth depend on new medicines versus increasing prices for existing medicines? Moreover, does using list prices, as is commonly done, instead of prices net of confidential rebates offered by manufacturers, which are... View Details

Keywords: Revenue; Price; Policy; Business Strategy; Pharmaceutical Industry

12 Jan 2016
First Look

January 12, 2016

link: https://www.hbs.edu/faculty/Pages/item.aspx?num=50304 October 2015 Health Affairs Exposure to Harmful Workplace Practices Could Account for Inequality in Life Spans Across Different Demographic Groups By: Goh, Joel, Jeffrey Pfeffer,... View Details

Keywords: Carmen Nobel

Article

The Business Case for Investing in Physician Well-Being

By: Tait D. Shanafelt, Joel Goh and Christine A. Sinsky

Importance: Widespread burnout among physicians has been recognized for more than two decades. Extensive evidence indicates that physician burnout has important personal and professional consequences.
Observations: A lack of awareness regarding... View Details

Keywords: Physicians; Well-being; ROI; Health; Welfare or Wellbeing; Ethics; Investment Return; Health Industry